Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jul 12 04:00PM ET
9.20
Dollar change
+0.11
Percentage change
1.21
%
Index- P/E65.71 EPS (ttm)0.14 Insider Own56.55% Shs Outstand4.84M Perf Week8.24%
Market Cap43.93M Forward P/E- EPS next Y- Insider Trans0.06% Shs Float2.10M Perf Month5.02%
Income- PEG- EPS next Q- Inst Own1.76% Short Float0.41% Perf Quarter3.72%
Sales0.16M P/S268.79 EPS this Y- Inst Trans- Short Ratio4.50 Perf Half Y13.72%
Book/sh7.08 P/B1.30 EPS next Y- ROA- Short Interest0.01M Perf Year-3.26%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range7.11 - 10.15 Perf YTD-4.17%
Dividend Est.- P/FCF- EPS past 5Y125.02% ROI- 52W High-9.36% Beta-0.54
Dividend TTM- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low29.40% ATR (14)0.31
Dividend Ex-DateJan 05, 2018 Current Ratio- EPS Y/Y TTM- Oper. Margin- RSI (14)53.20 Volatility2.58% 3.05%
Employees- Debt/Eq- Sales Y/Y TTM- Profit Margin- Recom2.00 Target Price23.25
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q-52.50% Payout- Rel Volume0.13 Prev Close9.09
Sales Surprise- EPS Surprise- Sales Q/Q-14.50% Earnings- Avg Volume1.93K Price9.20
SMA202.91% SMA50-1.46% SMA2003.00% Trades Volume258 Change1.21%
Date Action Analyst Rating Change Price Target Change
May-16-19Initiated Ascendiant Capital Markets Buy $20
Jul-11-24 08:00AM
Jun-18-24 08:00AM
Jun-05-24 08:00AM
Apr-16-24 08:00AM
Apr-15-24 08:00AM
08:00AM Loading…
Apr-10-24 08:00AM
Apr-01-24 08:00AM
Mar-28-24 10:38AM
Mar-25-24 08:00AM
Mar-22-24 08:00AM
Mar-18-24 02:18PM
02:18PM
Mar-11-24 08:00AM
Mar-08-24 08:00AM
Feb-26-24 08:00AM
08:00AM Loading…
Feb-12-24 08:00AM
Feb-07-24 08:00AM
Jan-29-24 08:00AM
Jan-16-24 08:00AM
Jan-09-24 08:00AM
Jan-02-24 08:30AM
Nov-13-23 08:00AM
Nov-09-23 08:00AM
Oct-13-23 08:00AM
Oct-11-23 08:00AM
Oct-04-23 08:00AM
Sep-27-23 08:00AM
Sep-26-23 08:00AM
Sep-11-23 12:00PM
Sep-07-23 09:15AM
04:15PM Loading…
Aug-28-23 04:15PM
04:05PM
Aug-10-23 08:00AM
Jul-12-23 08:00AM
Jul-11-23 08:00AM
Jul-05-23 08:00AM
Jun-22-23 04:15PM
Jun-20-23 08:00AM
Jun-15-23 08:00AM
Jun-12-23 08:00AM
May-25-23 03:37PM
May-22-23 08:30AM
May-19-23 04:53PM
May-18-23 08:00AM
Apr-20-23 08:00AM
Apr-17-23 08:00AM
Apr-13-23 08:00AM
Mar-27-23 08:00AM
Mar-23-23 08:30AM
08:00AM
Mar-03-23 08:00AM
Mar-02-23 07:00AM
Mar-01-23 08:00AM
Feb-17-23 08:00AM
Jan-19-23 08:00AM
Jan-13-23 08:00AM
Jan-03-23 08:00AM
Nov-17-22 11:07AM
Nov-15-22 08:45AM
Nov-14-22 05:03PM
Nov-10-22 08:00AM
Nov-03-22 08:00AM
Oct-31-22 08:00AM
Oct-05-22 08:30AM
Oct-04-22 08:30AM
08:00AM
Oct-03-22 09:00AM
08:40AM
08:00AM
Sep-26-22 08:00AM
Sep-06-22 05:05PM
Aug-29-22 08:00AM
Aug-25-22 04:05PM
Aug-24-22 04:40PM
Jul-27-22 08:00AM
Jul-21-22 08:00AM
Jul-18-22 08:00AM
Jun-27-22 08:00AM
Jun-13-22 08:00AM
May-25-22 08:00AM
May-12-22 08:00AM
May-02-22 08:00AM
Apr-06-22 08:00AM
Mar-23-22 08:00AM
Mar-01-22 09:00AM
08:00AM
Feb-17-22 08:00AM
Feb-02-22 08:00AM
Jan-21-22 08:00AM
Jan-20-22 04:05PM
Jan-06-22 08:00AM
Jan-05-22 08:00AM
Jan-04-22 08:00AM
Nov-16-21 08:00AM
Nov-09-21 08:00AM
Oct-01-21 08:30AM
Sep-14-21 08:30AM
Sep-08-21 08:30AM
Sep-07-21 08:30AM
Sep-01-21 08:30AM
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Michel Robert JChief Financial OfficerMar 27 '24Buy8.707506,52511,300Mar 27 01:35 PM
Feuer EdwardDirectorMar 04 '24Buy7.211,0007,2101,000Mar 06 04:18 PM
Michel Robert JChief Financial OfficerDec 06 '23Buy7.7512093010,550Dec 06 03:48 PM
Feldschuh Michael RichardChief Executive OfficerDec 01 '23Buy7.808006,240162,492Dec 01 08:58 PM
Michel Robert JChief Financial OfficerDec 01 '23Buy7.751801,39510,430Dec 01 09:00 PM
Michel Robert JChief Financial OfficerNov 24 '23Buy7.945003,97010,250Nov 27 06:03 AM
Feldschuh Michael RichardCHIEF EXECUTIVE OFFICERNov 10 '23Buy7.831,0017,838161,608Nov 13 06:33 AM
Feldschuh Michael RichardCHIEF EXECUTIVE OFFICERNov 09 '23Buy7.854013,148160,607Nov 13 06:33 AM
Michel Robert JChief Financial OfficerOct 13 '23Buy9.025004,5107,750Oct 16 12:41 PM